Clinical Trial Update: Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AGN 203818 for pain associated with interstitial cystitis/painful bladder syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• AGN-203818

Snippet

Sponsor: Allergan | Conditions: Cystitis, Interstitial | Phase 2 | Status: TERMINATED